Research Reports

Executive Summary Precision oncology is transforming cancer treatment by matching therapies to the genetic characteristics of each patient's tumor. Molecular profiling, next-generation sequencing (NGS), and biomarker testing allow clinicians to select targeted therapies with improved effectiveness and fewer adverse effects.

Executive Summary Artificial intelligence is improving cancer diagnosis, pathology, radiology, treatment planning, and clinical trial matching. AI is increasingly used to personalize treatment decisions and improve operational efficiency, while maintaining clinician oversight.

Executive Summary Liquid biopsy enables detection of tumor DNA, circulating tumor cells, and other biomarkers from blood samples. It offers a minimally invasive approach for diagnosis, treatment monitoring, and recurrence detection.

Executive Summary Immunotherapy has revolutionized treatment for several cancers by enabling the immune system to recognize and destroy tumor cells. Research continues to improve response rates and identify predictive biomarkers.

Overview Detailed study on predictive, prognostic, and diagnostic biomarkers, assessing FDA-approved biomarker tests and mapping their clinical significance for cancer therapeutics.

Overview A report exploring modern DNA sequencing technologies, examining clinical laboratory workflows, data interpretation strategies, and emerging oncology applications.

Overview An in-depth review mapping trials phases, patient recruitment strategies, decentralized clinical trials systems, enrollment diversity, and emerging designs.

Executive Summary Patient navigation programs help patients overcome barriers to diagnosis, treatment, financial assistance, and survivorship, leading to improved access to care and patient experience.

Overview A report focused on survivorship care planning, long-term treatment side effects, mental health support, nutrition guidelines, and exercise regimens.

Overview A global study surveying worldwide cancer incidence metrics, screening innovations, digital health growth, precision medicine, and future research priorities.